亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Clinical Genomic Analyses Demonstrate t(11;14) Multiple Myeloma Retains B-Cell Biology and Distinct Mitochondrial Metabolism That Convey Increased Sensitivity to BCL-2 Inhibition By Venetoclax

威尼斯人 生物 多发性骨髓瘤 癌症研究 遗传学 分子生物学 免疫学 白血病 慢性淋巴细胞白血病
作者
David Sharon,Fengjiao Dunbar,Paul Jung,Xifeng Wang,Xiaotong Li,Christine Mantis,Orlando F. Bueno,Cyrille Touzeau,Philippe Moreau,Simon J. Harrison,Luciano J. Costa,Jonathan L. Kaufman,Nizar J. Bahlis,Shaji Kumar,Jeremy A. Ross,PK Epling-Burnette
出处
期刊:Blood [Elsevier BV]
卷期号:140 (Supplement 1): 4242-4244
标识
DOI:10.1182/blood-2022-160195
摘要

Introduction: Venetoclax (Ven) is a selective, potent, oral BCL-2 inhibitor under investigation as a targeted therapy for t(11;14)-positive relapsed/refractory multiple myeloma (RRMM). The molecular mechanisms underlying the increased sensitivity of t(11;14) MM to Ven have not been fully elucidated; however, remnants of B-cell biology and reduced cellular bioenergetics have been associated with sensitivity to Ven in MM. Transcriptomic analysis of 302 RRMM patient tumor cells before treatment with Ven-based regimens, an ex vivo B-cell differentiation model, and metabolic profiling of 7 MM cell lines were assessed to understand the unique biology that distinguishes t(11;14) in MM. Methods: CD138-enriched bone marrow mononuclear cells were collected at baseline from multiple Ven clinical trials (NCT02755597, NCT01794520, NCT03314181, NCT02899052). Biomarker analyses, including BCL2 gene expression by quantitative PCR, t(11;14) status by interphase fluorescence in situ hybridization (FISH), and transcriptomic analysis by RNA sequencing (RNA-seq), were performed by a central laboratory. Isolated healthy memory B-cells (MBCs) were progressively differentiated ex vivo into pre-plasmablast (Pre-PB), plasmablast (PB), and plasma cells (PC). MM cell lines were differentiated by treatment with all-trans retinoic acid (ATRA) for 3-days. Global metabolomic profiling was performed by liquid chromatography-mass spectrometry (LC-MS) in MM cell lines with or without ATRA-mediated differentiation. Gene set variation analysis (GSVA) was used to establish B-cell and mitochondrial (Mito) gene signatures. Results: Consistent with previous findings, t(11;14)-positive RRMM expressed significantly higher CCND1 (mean log2 FPKM: 3.8 vs −0.4, P<.0001) and BCL2 levels (mean 2-ΔCt: 1.3 vs 0.4, P<.0001) compared with t(11;14)-negative RRMM. Using a network-based enrichment map to interrogate differentially expressed genes, transcriptomes of t(11;14)-positive samples were enriched in several pathways, including cell cycle, metabolism and biosynthesis, and immune pathways. Significantly higher B-cell signature scores, but lower Mito signature scores were detected in t(11;14)-positive versus t(11;14)-negative RRMM patients (P<.0001; Figure). The ex vivo B-cell differentiation model confirmed that B-cell and Mito scores are differentiation-stage specific and significantly changed upon differentiation to plasma cells (P<.0001). In RRMM patients, there was an inverse correlation between the B-cell and Mito signature scores (R=−0.6, P<.0001). In vitro models were then used to further investigate the relationship between B-cell differentiation and Ven sensitivity. ATRA differentiated t(11;14)-positive MM cell lines, as indicated by lower expression of CD20 and increased expression of the plasma cell markers CD138 and CD38, significantly reduced BCL2 expression and increased basal rates of respiration in association with increased mitochondrial mass, which correlated with reduced Ven sensitivity. Differentially expressed metabolites were overrepresented in the purine biosynthetic pathway in t(11;14)-positive MM cell lines, which was corroborated by differential gene expression within this pathway in the ex vivo B-cell differentiation model and in t(11;14)-positive RRMM patients. Using thresholds that balance sensitivity and specificity of the B-cell and Mito signature scores associated with t(11;14)-positive RRMM, progression-free survival (PFS) outcomes in the BELLINI study were not superior to those demonstrated by t(11;14) or high BCL2 expression status alone (Table). Conclusions: Using an integrated approach of transcriptomic and metabolomic profiling, t(11;14) MM cells were confirmed to retain features of B-cell biology, including lower Mito metabolism that results in increased sensitivity to BCL-2 inhibition by Ven. Although these biological features are closely linked to t(11;14), B-cell gene or Mito gene signatures did not serve as better biomarkers for predicting efficacy to Ven compared with t(11;14) alone. Figure 1View largeDownload PPTFigure 1View largeDownload PPT Close modal
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
8秒前
量子星尘发布了新的文献求助10
11秒前
Mei完成签到,获得积分10
37秒前
39秒前
香蕉觅云应助哈哈哈采纳,获得10
46秒前
46秒前
冷静大米完成签到,获得积分10
48秒前
1分钟前
冷静大米发布了新的文献求助10
1分钟前
1分钟前
1分钟前
1分钟前
量子星尘发布了新的文献求助10
1分钟前
顺心蜜粉应助紧张的书本采纳,获得10
2分钟前
今后应助echo采纳,获得10
2分钟前
立夏完成签到,获得积分10
3分钟前
量子星尘发布了新的文献求助10
3分钟前
lixuebin完成签到 ,获得积分10
3分钟前
gavin完成签到 ,获得积分10
3分钟前
腐竹完成签到,获得积分10
4分钟前
4分钟前
大气建辉完成签到 ,获得积分10
4分钟前
量子星尘发布了新的文献求助10
4分钟前
4分钟前
5分钟前
6分钟前
杪夏二八完成签到 ,获得积分10
6分钟前
量子星尘发布了新的文献求助10
6分钟前
6分钟前
科研通AI2S应助科研通管家采纳,获得10
7分钟前
义气雁完成签到 ,获得积分10
7分钟前
wodetaiyangLLL完成签到 ,获得积分10
7分钟前
7分钟前
7分钟前
7分钟前
Ava应助飞翔的企鹅采纳,获得10
7分钟前
7分钟前
量子星尘发布了新的文献求助10
8分钟前
8分钟前
noob_发布了新的文献求助20
8分钟前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 700
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3976665
求助须知:如何正确求助?哪些是违规求助? 3520770
关于积分的说明 11204801
捐赠科研通 3257528
什么是DOI,文献DOI怎么找? 1798733
邀请新用户注册赠送积分活动 877897
科研通“疑难数据库(出版商)”最低求助积分说明 806629